Arkolith/Insider Trading/TLIS/Form 4

Coe Brian

Chief Executive Officer, DirectorTalis Biomedical Corp (TLIS) · full profile →Form 4 · filed Feb 19, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2021Conversion(C)15K——18K
Feb 17, 2021Conversion(C)8K——26K
Feb 17, 2021Conversion(C)7K——33K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 17, 2021Conversion(C)22K—$00
Feb 17, 2021Conversion(C)11K—$00
Feb 17, 2021Conversion(C)12K—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-012510) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Talis Biomedical Corp

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp